EcoDrugPlus

Protein Kinase C Eta

Ensembl ID : ENSPSNG00000011826
Gene Symbol: PRKCH
3 Cross references
237 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSPSNG00000015378
Gene Symbol: PRKCG
3 Cross references
198 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSPSNG00000002428
Gene Symbol: PRKCI
3 Cross references
195 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSPSNG00000000301
Gene Symbol: PRKCQ
1 Cross references
203 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSPSNG00000001945
Gene Symbol: PRKCZ
3 Cross references
197 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSPSNG00000015859
Gene Symbol: PRKD1
3 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSPSNG00000014466
Gene Symbol: PRKD3
3 Cross references
270 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSPSNG00000002590
Gene Symbol: PRKACA
3 Cross references
283 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSPSNG00000003284
Gene Symbol: PRKACB
3 Cross references
297 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSPSNG00000016032
Gene Symbol: PRKDC
1 Cross references
184 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSPSNG00000017541
Gene Symbol: PPP3CA
3 Cross references
230 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSPSNG00000014133
Gene Symbol: PTK2
1 Cross references
322 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).